Competidores
Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
---|---|---|---|---|---|---|
NYSE:ABBV
AbbVie
|
166.42 | -23.06% | -12.89% | 293,875.72 | 3.73% | 7.03% |
SWX:NOVN
Novartis
|
93.37 | 8.15% | 21.52% | 190,512.74 | 3.53% | 4.67% |
NasdaqGS:AMGN
Amgen
|
312.47 | -12.26% | -3.47% | 167,619.75 | 2.88% | 5.31% |
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61.74% | 72.08% | 89,253.22 | 5.45% | 13.54% |
XTRA:MRK
Merck KGaA
|
167.20 | 2.96% | 17.7% | 72,694.86 | 1.32% | 10.73% |
TSE:4502
Takeda Pharmaceutical Company
|
4130.00 | 0% | 0% | 6,479,696.8 | 4.75% | 0% |
NasdaqGS:BIIB
Biogen
|
230.57 | -15.23% | -0.18% | 33,570.28 | 0% | -10.89% |
XTRA:BAYN
Bayer
|
28.58 | 67.53% | 83.89% | 28,077.68 | 0.38% | 1.47% |
ENXTBR:ARGX
argenx
|
339.90 | 0% | 0% | 20,200.62 | 0% | 0% |
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.29 | -46.21% | -42.74% | 18,450.72 | 0% | -2.6% |
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
51.20 | 18.28% | 30.99% | 10,363.08 | 2.34% | 10.99% |
CPSE:ZEAL
Zealand Pharma A/S
|
600.00 | 0% | 0% | 38,517.01 | 0% | 0% |
LSE:HIK
Hikma Pharmaceuticals PLC
|
19.78 | 25.31% | 38.17% | 4,424.39 | 2.86% | 10.04% |
HLSE:ORNBV
Orion Oyj
|
37.69 | 22.61% | 65.62% | 5,117.58 | 4.3% | -0.43% |
CPSE:ALK B
ALK-Abelló A/S
|
152.00 | 48.16% | 94.21% | 33,908.31 | 0% | 171.44% |
NasdaqGM:MRUS
Merus N.V.
|
43.91 | 0% | 0% | 2,612.77 | 0% | 0% |
LSE:INDV
Indivior PLC
|
13.37 | -23.61% | -1.68% | 1,952.43 | 0% | -2.7% |
NasdaqCM:TGTX
TG Therapeutics
|
16.48 | 0% | 0% | 2,379.32 | 0% | 0% |
BME:ALM
Almirall
|
9.27 | -45.22% | 27.15% | 1,944.22 | 2.05% | -30.96% |
NasdaqGM:XNCR
Xencor
|
23.03 | -,215.7% | -,162.26% | 1,315.88 | 0% | 0% |